IVBXF
Price
$12.10
Change
-$0.40 (-3.20%)
Updated
Sep 23 closing price
Capitalization
20.55B
MBXBF
Price
$0.19
Change
+$0.01 (+5.56%)
Updated
Sep 22 closing price
Capitalization
26.96M
Interact to see
Advertisement

IVBXF vs MBXBF

Header iconIVBXF vs MBXBF Comparison
Open Charts IVBXF vs MBXBFBanner chart's image
Innovent Biologics
Price$12.10
Change-$0.40 (-3.20%)
Volume$2.18K
Capitalization20.55B
Microbix Biosystems
Price$0.19
Change+$0.01 (+5.56%)
Volume$6K
Capitalization26.96M
IVBXF vs MBXBF Comparison Chart in %
Loading...
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVBXF vs. MBXBF commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVBXF is a Hold and MBXBF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (IVBXF: $12.10 vs. MBXBF: $0.19)
Brand notoriety: IVBXF and MBXBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVBXF: 4% vs. MBXBF: 5%
Market capitalization -- IVBXF: $20.55B vs. MBXBF: $26.96M
IVBXF [@Biotechnology] is valued at $20.55B. MBXBF’s [@Biotechnology] market capitalization is $26.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVBXF’s FA Score shows that 0 FA rating(s) are green whileMBXBF’s FA Score has 1 green FA rating(s).

  • IVBXF’s FA Score: 0 green, 5 red.
  • MBXBF’s FA Score: 1 green, 4 red.
According to our system of comparison, IVBXF is a better buy in the long-term than MBXBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVBXF’s TA Score shows that 3 TA indicator(s) are bullish while MBXBF’s TA Score has 2 bullish TA indicator(s).

  • IVBXF’s TA Score: 3 bullish, 5 bearish.
  • MBXBF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, IVBXF is a better buy in the short-term than MBXBF.

Price Growth

IVBXF (@Biotechnology) experienced а -6.92% price change this week, while MBXBF (@Biotechnology) price change was +14.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVBXF($20.5B) has a higher market cap than MBXBF($27M). IVBXF has higher P/E ratio than MBXBF: IVBXF (128.47) vs MBXBF (22.25). IVBXF YTD gains are higher at: 168.889 vs. MBXBF (-34.256).
IVBXFMBXBFIVBXF / MBXBF
Capitalization20.5B27M75,926%
EBITDAN/A2.47M-
Gain YTD168.889-34.256-493%
P/E Ratio128.4722.25577%
RevenueN/A21.1M-
Total CashN/A12.1M-
Total DebtN/A6.41M-
FUNDAMENTALS RATINGS
IVBXF vs MBXBF: Fundamental Ratings
IVBXF
MBXBF
OUTLOOK RATING
1..100
9711
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
9792
PRICE GROWTH RATING
1..100
3863
P/E GROWTH RATING
1..100
618
SEASONALITY SCORE
1..100
3850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBXBF's Valuation (73) in the null industry is in the same range as IVBXF (85). This means that MBXBF’s stock grew similarly to IVBXF’s over the last 12 months.

IVBXF's Profit vs Risk Rating (66) in the null industry is somewhat better than the same rating for MBXBF (100). This means that IVBXF’s stock grew somewhat faster than MBXBF’s over the last 12 months.

MBXBF's SMR Rating (92) in the null industry is in the same range as IVBXF (97). This means that MBXBF’s stock grew similarly to IVBXF’s over the last 12 months.

IVBXF's Price Growth Rating (38) in the null industry is in the same range as MBXBF (63). This means that IVBXF’s stock grew similarly to MBXBF’s over the last 12 months.

MBXBF's P/E Growth Rating (8) in the null industry is somewhat better than the same rating for IVBXF (61). This means that MBXBF’s stock grew somewhat faster than IVBXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IVBXFMBXBF
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bearish Trend 1 day ago
59%
Bullish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
62%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 13 days ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
56%
Bearish Trend 23 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBLOF0.95N/A
N/A
Public Bank Ltd
MDTWF2.15N/A
N/A
Mediterranean Towers LTD
PMMCF0.22-0.01
-3.51%
Andina Copper Corporation
XISHY8.42-0.35
-3.96%
Xinyi Solar Holdings Limited
CRTD0.25-0.02
-7.44%
CREATD INC.

IVBXF and

Correlation & Price change

A.I.dvisor tells us that IVBXF and WXXWY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVBXF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVBXF
1D Price
Change %
IVBXF100%
-3.20%
WXXWY - IVBXF
24%
Poorly correlated
-0.17%
BNTC - IVBXF
23%
Poorly correlated
-2.15%
MBXBF - IVBXF
7%
Poorly correlated
N/A
ISCO - IVBXF
5%
Poorly correlated
N/A
IDRSF - IVBXF
4%
Poorly correlated
+42.42%
More

MBXBF and

Correlation & Price change

A.I.dvisor tells us that MBXBF and CMND have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBXBF and CMND's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBXBF
1D Price
Change %
MBXBF100%
N/A
CMND - MBXBF
25%
Poorly correlated
-7.27%
BVNRY - MBXBF
20%
Poorly correlated
-0.12%
MMIRF - MBXBF
15%
Poorly correlated
N/A
IVEVF - MBXBF
8%
Poorly correlated
N/A
IVBXF - MBXBF
7%
Poorly correlated
-3.20%
More